Login

Mangold Insight interviews tech company DLTx, delving into discussions on AI competitiveness with a reference to C3.ai. 00:10:00

Share On Facebook Share On Twitter

DLTx's founder is Timothy Furey.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Barclays CEO Discusses Shifts in Banking Landscape and Strategic Focus | C.S. Venkatakrishnan , CEO , Barclays.
00:10:00
DIS & Product Tankers Update: CFO Insights - Capital Link Presentation 2020 | Carlos Balestra di Mottola - Chief Executive Officer of d'Amico International Shipping S.A.
00:10:00
Charting Course: Cadeler A/S (CDLR) (CADLR) Update & Outlook | Mikkel Gleerup - CEO of Cadeler A/S
00:10:00
Steve Humphreys, Identiv CEO, elucidates the company's mission to enhance global security and responsiveness across diverse sectors through innovative technology solutions.|Steve Humphreys, CEO of Identiv
00:10:00
backs brilliant founders working in blockchain|Chandler Guo,Managing Partner,AU21 Capital
00:10:00
Prof. Thornton on Europe's Cultural and Economic Decline|Bruce Thornton
00:10:00
Zigg Capital: Pioneering the Future of Real Estate and Technology Investments with a $335 Million Vision|Dave Eisenberg Founding Partner at Zigg Capital
00:10:00
Mark Barrenechea, CEO of OpenText Corp., discusses his favorite city, restaurant, and travel experiences.
00:10:00
Exploring High-Potential Gold and Lithium Projects in Quebec and Nunavik
00:10:00
Penguin Alma Palladium Project: Unveiling Potential in South Africa
00:10:00
From Local Success to Stock Exchange: The Fascinating Journey
00:10:00
Clear Skies Investment Management: Leading Impact Investing with Climate Change Solutions

© 2017 - Neuhu+